(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE INOSITOL

ArquivadaInvention PatentPCT · EP2018086182

Application data

Number

112020012687

Type

Invention Patent

Filing

12/20/2018

Publication

11/24/2020

PCT

EP2018086182

Progress at the INPI

  1. Filing12/20/18
  2. Publication11/24/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/13/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

LO.LI. PHARMA INTERNATIONAL S.R.L.

IT

LO.LI. PHARMA S.R.L.

IT

Inventors

V. U. (pessoa física)

IT

Technical data

IPC Classification

Priority claims

IT

102017000148902 · 12/22/2017

Abstract

A presente invenção se refere ao uso médico de inositol para o tratamento de fibrose muscular reativa, por exemplo, fibrose cardíaca reativa, em um indivíduo. A presente invenção se refere ainda a métodos de tratamento de fibrose muscular reativa, por exemplo, fibrose cardíaca reativa, pela administração de inositol a um indivíduo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

12/13/2022

RPI 2710

Parecer de pré-exame

#6.23

09/06/2022

RPI 2696

Adição na publicação

#15.35

12/07/2021

RPI 2657

Transferência deferida

#25.1

10/13/2021

RPI 2649

Notificação de entrada na fase nacional - PCT

#1.3

11/24/2020

RPI 2603

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.